{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:42:08Z","timestamp":1782776528541,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T00:00:00Z","timestamp":1545609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical University of Silesia in Katowice","award":["KNW-1-004\/N\/7\/0"],"award-info":[{"award-number":["KNW-1-004\/N\/7\/0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11255-018-2050-3","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T08:26:19Z","timestamp":1545639979000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Relationship between plasma levels of sclerostin, calcium\u2013phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients"],"prefix":"10.1007","volume":"51","author":[{"given":"Barbara","family":"Pietrzyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wyskida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ficek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aureliusz","family":"Kolonko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Ficek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Olszanecka-Glinianowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Chudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","volume":"87","author":"MJ Moester","year":"2010","unstructured":"Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL (2010) Sclerostin: Current knowledge and future perspectives. Calcif Tissue Int 87:99\u2013107 1","journal-title":"Calcif Tissue Int"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1172\/JCI33612","volume":"118","author":"S Khosla","year":"2008","unstructured":"Khosla S, Westendorf JJ, Oursler MJ (2008) Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118:421\u2013428","journal-title":"J Clin Invest"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jcb.21151","volume":"101","author":"L Cianferotti","year":"2007","unstructured":"Cianferotti L, Demay MB (2007) VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101:80\u201388","journal-title":"J Cell Biochem"},{"key":"2050_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jcp.21267","volume":"214","author":"L Carvallo","year":"2008","unstructured":"Carvallo L, Henr\u00edquez B, Paredes R et al (2008) 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1-alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex. J Cell Physiol 214:740\u2013749","journal-title":"J Cell Physiol"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jbmr.226","volume":"26","author":"Y Lu","year":"2011","unstructured":"Lu Y, Yuan B, Qin C et al (2011) The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res 26:331\u2013340","journal-title":"J Bone Miner Res"},{"key":"2050_CR6","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1210\/jc.2013-3958","volume":"99","author":"CL Gregson","year":"2014","unstructured":"Gregson CL, Poole KE, McCloskey et al (2014) Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations. J Clin Endocrinol Metab 99: 2897\u20132907. \n                    https:\/\/doi.org\/10.1210\/jc.2013-3958","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR7","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/jbmr.479","volume":"26","author":"MS Ardawi","year":"2011","unstructured":"Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26:2812\u20132822","journal-title":"J Bone Miner Res"},{"key":"2050_CR8","doi-asserted-by":"publisher","unstructured":"Moe SM, Drueke TB, Block GA, Cannata-Andia JB et al (2009) KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease\u2014Mineral and Bone Disorder (CKD-MBD); Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD, Work Group Am. Kidney Int Suppl (113): S1\u2013S130. \n                    https:\/\/doi.org\/10.1038\/ki.2009.188","DOI":"10.1038\/ki.2009.188"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) National Osteoporosis Foundation: Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"2050_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2215\/CJN.06550810","volume":"6","author":"D Cejka","year":"2011","unstructured":"Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH (2011) Sclerostin and Dickkopf-1in renal osteodystrophy. Clin J Am Soc Nephrol 6: 877\u2013882. \n                    https:\/\/doi.org\/10.2215\/CJN.06550810","journal-title":"Clin J Am Soc Nephrol"},{"key":"2050_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00774-005-0665-9","volume":"24","author":"M Rodriguez","year":"2006","unstructured":"Rodriguez M, Ca\u00f1adillas S, Lopez I, Aguilera-Tejero E, Almaden Y (2006) Regulation of parathyroid function in chronic renal failure. J Bone Miner Metab 24:164\u2013168","journal-title":"J Bone Miner Metab"},{"key":"2050_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/sji.12392","volume":"83","author":"G Almroth","year":"2015","unstructured":"Almroth G, L\u00f6nn J, Uhlin F, Brudin L, Andersson B, Hahn-Zoric M (2015) Sclerostin, TNF-alpha and Interleukin-18 Correlate and are Together with Klotho Related to Other Growth Factors and Cytokines in Haemodialysis Patients. Scand J Immunol 83:58\u201363","journal-title":"Scand J Immunol"},{"key":"2050_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s11255-016-1495-5","volume":"49","author":"J Ficek","year":"2017","unstructured":"Ficek J, Wyskida K, Ficek R et al (2017) Relationship between plasma levels of zonulin, bacterial lipopolysaccharides, D-lactate and markers of inflammation in haemodialysis patients. Int Urol Nephrol 49:717\u2013725. \n                    https:\/\/doi.org\/10.1007\/s11255-016-1495-5","journal-title":"Int Urol Nephrol"},{"key":"2050_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","volume":"90","author":"S Thambiah","year":"2012","unstructured":"Thambiah S, Roplekar R, Manghat P, Fogelman I, Fraser W, Goldsmith D, Hampson G (2012) Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Calcif Tissue Int 90:473\u2013480","journal-title":"Calcif Tissue Int"},{"key":"2050_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000355781","volume":"39","author":"M Bonani","year":"2014","unstructured":"Bonani M, Rodriguez D, Fehr T, Mohebbi N, Brockmann J, Blum M, Graf N, Frey D, Wuthrich RP (2014) Sclerostin blood levels before and after kidney transplantation. Kidney Blood Press Res 39:230\u2013239","journal-title":"Kidney Blood Press Res"},{"key":"2050_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA Oliveira de","year":"2015","unstructured":"de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moys\u00e9s RM, Jorgetti V (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87:1039\u20131045. \n                    https:\/\/doi.org\/10.1038\/ki.2014.372","journal-title":"Kidney Int"},{"key":"2050_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/bmm-2016-0031","volume":"10","author":"S Jin","year":"2016","unstructured":"Jin S, Zhu M, Yan J, Fang Y, Lu R, Zhang W, Zhang Q, Lu J, Qi C, Shao X, Zhang H, Jiang R, Ni Z (2016) Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients. Biomark Med 10:689\u2013699","journal-title":"Biomark Med"},{"key":"2050_CR18","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling - Hampton K (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267\u20136276","journal-title":"EMBO J"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"e0176411","DOI":"10.1371\/journal.pone.0176411","volume":"12","author":"GJ Behets","year":"2017","unstructured":"Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D\u2019Haese PC, Evenepoel P (2017) Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. PLoS ONE 12: e0176411. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0176411\n                    \n                  . eCollection 2017","journal-title":"PLoS ONE"},{"key":"2050_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000366449","volume":"128","author":"P Delanaye","year":"2014","unstructured":"Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Medart L et al (2014) Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron Clin Pract 128:127\u2013134. \n                    https:\/\/doi.org\/10.1159\/000366449","journal-title":"Nephron Clin Pract"},{"key":"2050_CR21","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1210\/jc.2014-2372","volume":"99","author":"E Ishimura","year":"2014","unstructured":"Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S et al (2014) Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients. J Clin Endocrinol Metab 99: 4315\u20134320. \n                    https:\/\/doi.org\/10.1210\/jc.2014-2372","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ndt\/gfr270","volume":"27","author":"D Cejka","year":"2012","unstructured":"Cejka D, Jager-Lansky A, Kieweg H, Weber M, Bieglmayer C, Haider DG et al (2012) Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 27: 226\u2013230. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfr270","journal-title":"Nephrol Dial Transplant"},{"key":"2050_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","volume":"37","author":"H Keller","year":"2005","unstructured":"Keller H, Kneissel M (2005) SOST is a target gene for PTH in bone. Bone 37:148\u2013158","journal-title":"Bone"},{"key":"2050_CR24","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O\u2019Brien CA, Manolagas SC, Jilka RL (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577\u20134583","journal-title":"Endocrinology"},{"key":"2050_CR25","doi-asserted-by":"publisher","first-page":"1e11","DOI":"10.1016\/j.mce.2015.06.021","volume":"413","author":"AR Wijenayaka","year":"2015","unstructured":"Wijenayaka AR, Yang D, Prideaux M, Ito N, Kogawa M, Anderson PH et al (2015) 1a,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Mol Cell Endocrinol 413:1e11","journal-title":"Mol Cell Endocrinol"},{"key":"2050_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.numecd.2016.11.005","volume":"27","author":"C Torino","year":"2017","unstructured":"Torino C, Pizzini P, Cutrupi S, Tripepi G, Mallamaci F, Thadhani R, Zoccali C (2017) Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels. Nutr Metab Cardiovasc Dis 27:260\u2013266","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2050_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jsbmb.2018.01.007","volume":"180","author":"AK Yadav","year":"2018","unstructured":"Yadav AK, Kumar V, Banerjee D, Gupta KL, Jha V (2018) Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease. J Steroid Biochem Mol Biol 180:15\u201318. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2018.01.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2050_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1055\/s-0035-1559790","volume":"125","author":"F Ac\u0131bucu","year":"2017","unstructured":"Ac\u0131bucu F, Dokmetas HS, Ac\u0131bucu DO, K\u0131l\u0131cl\u0131 F, Aydemir M, Cakmak E (2017) Effect of Vitamin D Treatment on Serum Sclerostin Level. Exp Clin Endocrinol Diabetes 125:634\u2013637","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2050_CR29","doi-asserted-by":"publisher","first-page":"1370e8","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370e8","journal-title":"Kidney Int"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1159\/000443452","volume":"41","author":"M Bo\u017centowicz-Wikarek","year":"2016","unstructured":"Bo\u017centowicz-Wikarek M, Owczarek A, Koce\u0142ak P, Olszanecka-Glinianowicz M, Wi\u0119cek A, Chudek J (2016) C-terminal to intact fibroblast growth factor 23 ratio in relation to estimated glomerular filtration rate in elderly population. Kidney Blood Press Res 41:519\u2013526","journal-title":"Kidney Blood Press Res"},{"key":"2050_CR31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00198-014-2934-8","volume":"26","author":"Y Asamiya","year":"2015","unstructured":"Asamiya Y, Yajima A, Shimizu S, Otsubo S, Tsuchiya K, Nitta K (2015) Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level. Osteoporos Int 26:1017\u20131028","journal-title":"Osteoporos Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-2050-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-2050-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-2050-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:02:44Z","timestamp":1577145764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-2050-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-2050-3","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,24]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration with its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}